Annual Revenue
$91.28 M
+$74.12 M+432.03%
December 31, 2024
Summary
- As of March 14, 2025, ANAB annual revenue is $91.28 million, with the most recent change of +$74.12 million (+432.03%) on December 31, 2024.
- During the last 3 years, ANAB annual revenue has risen by +$28.11 million (+44.49%).
- ANAB annual revenue is now at all-time high.
Performance
ANAB Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$43.11 M
+$13.10 M+43.63%
December 31, 2024
Summary
- As of March 14, 2025, ANAB quarterly revenue is $43.11 million, with the most recent change of +$13.10 million (+43.63%) on December 31, 2024.
- Over the past year, ANAB quarterly revenue has increased by +$13.10 million (+43.63%).
- ANAB quarterly revenue is now -28.15% below its all-time high of $60.00 million, reached on December 31, 2020.
Performance
ANAB Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$91.28 M
+$34.11 M+59.66%
December 31, 2024
Summary
- As of March 14, 2025, ANAB TTM revenue is $91.28 million, with the most recent change of +$34.11 million (+59.66%) on December 31, 2024.
- Over the past year, ANAB TTM revenue has increased by +$34.11 million (+59.66%).
- ANAB TTM revenue is now -25.28% below its all-time high of $122.16 million, reached on September 30, 2021.
Performance
ANAB TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ANAB Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +432.0% | +43.6% | +59.7% |
| 3 y3 years | +44.5% | +4164.4% | +44.5% |
| 5 y5 years | +1041.0% | +1337.1% | +1041.0% |
ANAB Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +787.3% | at high | +4344.6% | at high | +1933.0% |
| 5 y | 5-year | at high | +1041.0% | -28.1% | +4344.6% | -25.3% | +1933.0% |
| alltime | all time | at high | +1725.6% | -28.1% | +4344.6% | -25.3% | +1933.0% |
AnaptysBio Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $91.28 M(+432.0%) | $43.11 M(+43.6%) | $91.28 M(+59.7%) |
| Sep 2024 | - | $30.02 M(+173.6%) | $57.17 M(+87.6%) |
| Jun 2024 | - | $10.97 M(+52.8%) | $30.47 M(+32.7%) |
| Mar 2024 | - | $7.18 M(-20.3%) | $22.96 M(+33.8%) |
| Dec 2023 | $17.16 M(+66.8%) | $9.01 M(+171.4%) | $17.16 M(+14.7%) |
| Sep 2023 | - | $3.32 M(-4.1%) | $14.96 M(+15.7%) |
| Jun 2023 | - | $3.46 M(+151.8%) | $12.94 M(+21.0%) |
| Mar 2023 | - | $1.37 M(-79.8%) | $10.69 M(+3.9%) |
| Dec 2022 | $10.29 M(-83.7%) | $6.81 M(+426.5%) | $10.29 M(+129.1%) |
| Sep 2022 | - | $1.29 M(+6.3%) | $4.49 M(-81.4%) |
| Jun 2022 | - | $1.22 M(+25.4%) | $24.09 M(-54.5%) |
| Mar 2022 | - | $970.00 K(-4.1%) | $52.90 M(-16.3%) |
| Dec 2021 | $63.17 M(-15.8%) | $1.01 M(-95.2%) | $63.17 M(-48.3%) |
| Sep 2021 | - | $20.89 M(-30.4%) | $122.16 M(+20.6%) |
| Jun 2021 | - | $30.03 M(+167.0%) | $101.27 M(+42.1%) |
| Mar 2021 | - | $11.25 M(-81.3%) | $71.25 M(-5.0%) |
| Dec 2020 | $75.00 M | $60.00 M(+300.0%) | $75.00 M(+226.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $15.00 M(+400.0%) | $23.00 M(+187.5%) |
| Dec 2019 | $8.00 M(+60.0%) | $3.00 M(-40.0%) | $8.00 M(-20.0%) |
| Jun 2019 | - | $5.00 M(0.0%) | $10.00 M(+25.0%) |
| Dec 2018 | $5.00 M(-50.0%) | - | - |
| Sep 2018 | - | $5.00 M(+66.7%) | $8.00 M(-20.0%) |
| Dec 2017 | $10.00 M(-40.1%) | $3.00 M(-57.1%) | $10.00 M(-22.9%) |
| Jun 2017 | - | $7.00 M(+154.2%) | $12.97 M(-22.3%) |
| Dec 2016 | $16.68 M(-5.0%) | $2.75 M(-14.3%) | $16.68 M(-7.2%) |
| Sep 2016 | - | $3.21 M(-45.1%) | $17.98 M(-6.9%) |
| Jun 2016 | - | $5.85 M(+20.2%) | $19.31 M(+5.3%) |
| Mar 2016 | - | $4.87 M(+20.0%) | $18.34 M(+4.4%) |
| Dec 2015 | $17.57 M(+10.9%) | $4.05 M(-10.7%) | $17.57 M(+2.0%) |
| Sep 2015 | - | $4.54 M(-7.0%) | $17.22 M(-8.6%) |
| Jun 2015 | - | $4.88 M(+19.2%) | $18.84 M(+35.0%) |
| Mar 2015 | - | $4.10 M(+10.6%) | $13.96 M(+41.6%) |
| Dec 2014 | $15.84 M(+188.9%) | $3.71 M(-39.8%) | $9.86 M(+60.2%) |
| Sep 2014 | - | $6.15 M | $6.15 M |
| Dec 2013 | $5.48 M | - | - |
FAQ
- What is AnaptysBio annual revenue?
- What is the all time high annual revenue for AnaptysBio?
- What is AnaptysBio annual revenue year-on-year change?
- What is AnaptysBio quarterly revenue?
- What is the all time high quarterly revenue for AnaptysBio?
- What is AnaptysBio quarterly revenue year-on-year change?
- What is AnaptysBio TTM revenue?
- What is the all time high TTM revenue for AnaptysBio?
- What is AnaptysBio TTM revenue year-on-year change?
What is AnaptysBio annual revenue?
The current annual revenue of ANAB is $91.28 M
What is the all time high annual revenue for AnaptysBio?
AnaptysBio all-time high annual revenue is $91.28 M
What is AnaptysBio annual revenue year-on-year change?
Over the past year, ANAB annual revenue has changed by +$74.12 M (+432.03%)
What is AnaptysBio quarterly revenue?
The current quarterly revenue of ANAB is $43.11 M
What is the all time high quarterly revenue for AnaptysBio?
AnaptysBio all-time high quarterly revenue is $60.00 M
What is AnaptysBio quarterly revenue year-on-year change?
Over the past year, ANAB quarterly revenue has changed by +$13.10 M (+43.63%)
What is AnaptysBio TTM revenue?
The current TTM revenue of ANAB is $91.28 M
What is the all time high TTM revenue for AnaptysBio?
AnaptysBio all-time high TTM revenue is $122.16 M
What is AnaptysBio TTM revenue year-on-year change?
Over the past year, ANAB TTM revenue has changed by +$34.11 M (+59.66%)